Escalation in Ukraine Conflict Hypersonic Missile Attack Stirs Market Geopolitical Concerns DICKS Sporting Goods Reports First Quarter Financial Results Paytm Block Deal Societe Generale Ghisallo Viridian Lead Buyers in Rs 964 Crore Stake Sale Indias Strategic Pivot Modis Europe Trip Secures Tech and Defense Deals to Diversify Away from China and US Dependence Hong Kongs Gold Hub Ambitions Get Boost with New Clearing System Set for July Launch StateOwned Fuel Retailers Face Daily Losses of Nearly 600 Crore Despite Recent Price Hikes CelSci Corporation CVM Q4 2024 Earnings Narrower Loss Beats Estimates Stock Slips Teekay Corporation TK Q1 2026 Earnings Profitability Amid Market Volatility SKE Q1 2026 Earnings Significant EPS Miss Amid Exploration Stage Operations Thermo Fisher Scientific Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Pullback OSS Q1 2026 Earnings Strong EPS Surprise Drives Stock Rally Saga Communications SGA Q1 2026 Earnings Negative EPS of 043 Reflects Persistent Industry Headwinds Sprott Focus Trust Inc FUND Edges Higher as Precious Metals Fund Holds Near Key Support Artius II Acquisition Rights AACBR Hold Steady at 025 as Traders Watch Key Levels Barrick Mining B Surges 265 Bullish Momentum Testing Key Resistance Levels First Trust Senior Floating Rate Income Fund II FCT Edges Higher as Floating Rate Exposure Provides Stability Synopsys SNPS Declines 158 as Shares Approach Critical Support Level BETRW Warrants Plunge 1579 as Support Level Nears Critical Test PLUS THERAPEUTICS PSTV Slips 316 as Shares Test Key Support Amid Biotech Jitters Penguin Solutions Inc PENG Rallies 327 as Buyers Test Critical Resistance Near 577 INNOVATE Corp VATE Gains 374 as Price Approaches Key Resistance Level John B Sanfilippo Son JBSS Edges Higher as Stock Holds Above Key Support Manhattan Associates MANH Rallies 3 as Stock Approaches Key Resistance Level AIDriven NBFCs Reshaping Indias Credit Landscape with Intelligent Lending TXO Partners Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Operational Challenges Janux Therapeutics JANX Edges Higher as Stock Tests Key Support Zone